Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/2667
Nаziv: | The redox couple avarol/avarone in the fight with malignant gliomas: the case study of U-251 MG cells | Аutоri: | Pejin B. Tommonaro G. Glumac M. Jakimov D. Kojić, Vesna |
Dаtum izdаvаnjа: | 4-мар-2018 | Čаsоpis: | Natural Product Research | Sažetak: | © 2017 Informa UK Limited, trading as Taylor & Francis Group. This study aimed to screen in vitro antitumour activity of the redox couple avarol/avarone against the human malignant glioma cell line U-251 MG for the first time. Compared both with avarol and positive controls used (temozolomide and doxorubicin), avarone was found to be the most active compound with IC50 value below 1 μM (IC50 0.68 ± 0.04 μM, 96 h). Considerable less DNA damage in the cells treated with avarol and avarone vs. doxorubicin (105 & 123% vs. 299%, respectively; untreated U-251 MG cells were used as a control, 100%), coupled with no sign of cytotoxicity against the normal human foetal lung fibroblast MRC-5 cells (IC50 > 100 μM), has actually pointed out the importance of this marine sesquiterpenoid quinone structure as a promising lead compound in development of novel brain chemotherapeutics. | URI: | https://open.uns.ac.rs/handle/123456789/2667 | ISSN: | 14786419 | DOI: | 10.1080/14786419.2017.1327959 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
SCOPUSTM
Nаvоđеnjа
8
prоvеrеnо 10.05.2024.
Prеglеd/i stаnicа
20
Prоtеklа nеdеljа
7
7
Prоtеkli mеsеc
0
0
prоvеrеnо 10.05.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.